Cymbalta Suicide Suit Settled


Eli Lilly & Co. will pay an undisclosed amount to settle the lawsuit of the parents of a South Dakota boy who committed suicide four weeks after starting the antidepressant Cymbalta. The lawsuit, which was to go to trial next month, that Lilly failed to adequately warn patients that the drug was known to cause suicidal inclinations, and that a 19-year-old student had committed suicide by hanging while participating in a trial of the drug for urinary incontinence.

Article →

Previous articleVA Still Using Benzos for PTSD Despite Warnings
Next article“The D.S.M. and the Nature of Disease”
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].